E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Age-Related Changes in the Clinical Picture of Long COVID.
Fain, Mindy J, Horne, Benjamin D, Horwitz, Leora I et al. · Journal of the American Geriatrics Society · 2025 · DOI
Quick Summary
This study looked at how Long COVID symptoms change as people get older. Researchers compared people aged 18–39 with those aged 40–70+ who had recovered from COVID-19 infection at least 135 days earlier. They found that middle-aged adults (40–59) were more likely to have Long COVID than young adults, but surprisingly, adults aged 70+ were actually less likely to report it—and when they did, their symptoms looked different, with less fatigue, pain, and brain fog compared to younger people.
Why It Matters
This study highlights that Long COVID presents differently in older adults, which may lead to underdiagnosis or misattribution of symptoms to normal aging. Understanding age-specific symptom patterns is critical for developing targeted diagnostic criteria, treatment approaches, and rehabilitation strategies across the lifespan, particularly relevant as ME/CFS affects patients of all ages.
Observed Findings
Peak Long COVID prevalence occurred in the 40–59 age group (OR 1.31–1.40), significantly higher than young adults aged 18–39.
Adults aged ≥70 showed lower odds of meeting Long COVID criteria (OR 0.68, p < 0.001) compared to the youngest group.
Eight key symptoms (fatigue, pain syndromes, PEM, sleep disturbance, palpitations, hair loss, hearing loss, sexual dysfunction) showed reduced discriminatory value in adults ≥70.
Symptom clustering patterns shifted markedly with age: anosmia/ageusia clusters (1) became more common in older adults, while brain fog–dominant clusters (3–4) became significantly less common (relative risk ratios 0.10–0.34).
Inferred Conclusions
Aging fundamentally alters both the prevalence and phenotypic presentation of Long COVID, with middle-aged adults at highest risk and older adults showing atypical, less distinctive symptom profiles.
Traditional Long COVID diagnostic criteria and symptom clusters may perform poorly in older populations, necessitating age-adjusted case definitions.
The reduced discriminatory value of cardinal symptoms like fatigue and PEM in older adults suggests potential misdiagnosis or underrecognition of Long COVID in geriatric populations.
Remaining Questions
Why does Long COVID prevalence peak in the 40–59 age group before declining in those ≥70—is this a true biological effect or explained by survival bias and cohort-specific factors?
What This Study Does Not Prove
This observational study cannot establish causation or explain why aging alters Long COVID presentation. The lower prevalence in adults ≥70 may reflect survival bias (sicker individuals may not have survived to participate) or recall bias rather than true biological age effects. Results are specific to community-dwelling survivors and may not generalize to hospitalized or institutionalized populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
What mechanisms drive the age-related shift in symptom clustering, and are these patterns reflective of different viral pathophysiology or host immunological responses by age?
How do age-adjusted diagnostic criteria and treatment protocols need to be modified to improve Long COVID recognition and management in older adults?
Does the apparent lower prevalence in adults ≥70 represent true resistance to long-term COVID sequelae, or does it reflect ascertainment bias in community-dwelling survivors?